Professional Documents
Culture Documents
United Envirotech
Bloomberg: UENV SP | Reuters: UNIT.SI
2 Jan 2013
Price Relative
S$ 0.6 300 0.5 0.4 0.3 0.2 0.1 Jan-09 250 200 150 100 50 Jan-13 Relative Index
Jan-10
Jan-11
Jan-12
Potential upside from acquisitions & expansion; CB dilution can be potential overhang >60% of profits coming from long-term recurring treatment income. United Envirotech (UENV), a membrane-based wastewater treatment company, has been shifting to a stable, recurring and more profitable earnings profile with the acquisition of operating water plants in China. By FY14Mar, UENV would have a total processing capacity of 1.18b m3/day to generate S$25m or 60% of group PATMI. This treatment income is recurring for the life of the water concessions (30 yrs). Key beneficiary of Chinas rapid growth in environmental protection. Besides treatment services, UENV should continue to win engineering and construction (EPC) contracts given the growing demand for membrane-based water treatment plants in China to meet stricter discharge limits, which old plants are not equipped to process. We believe UENV can maintain ~Rmb400m of new EPC orders over the next two years. Earnings CAGR of 46% from FY13F-FY15F. UENV has potential upside from higher utilisation rates. Besides, we have not incorporated the Phase 2 expansion or acquisitions. BUY, TP S$0.69. Our sum-of-parts TP is based on 10x PE for EPC and DCF valuation (8.6% WACC) for treatment. We have also assumed full dilution of the S$136.2m convertible bond to Kholberg Kravis Roberts & Co (KKR).
At A Glance Issued Capital / Fully Diluted (m shrs) Mkt. Cap (S$m/US$m) Major Shareholders Yu Cheng Lin (%) Ching Wah Goh (%) Oei Hong Leong Peter (%) Free Float (%) Avg. Daily Vol.(000) 479 / 793.1 239 / 196 18.1 17.8 17.6 46.5 1,637
Turnover EBITDA Pre-tax Profit Net Profit Net Pft (Pre Ex.) EPS (S cts) EPS Pre Ex. (S cts) EPS Gth (%) EPS Gth Pre Ex (%) Diluted EPS (S cts) Net DPS (S cts) BV Per Share (S cts) PE (X) PE Pre Ex. (X) P/Cash Flow (X) EV/EBITDA (X) Net Div Yield (%) P/Book Value (X) Net Debt/Equity (X) ROAE (%) Consensus EPS (S cts): Other Broker Recs:
85 21 14 10 10 2.2 2.2 (35) (35) 2.2 0.3 37.3 22.8 22.8 49.3 15.4 0.6 1.3 0.5 6.6
150 49 36 27 27 5.5 5.5 149 149 5.5 0.7 41.1 9.1 9.1 7.5 8.5 1.5 1.2 0.9 14.1 4.8 B: 1
164 68 63 47 47 5.9 5.9 8 8 5.9 0.8 45.3 8.4 8.4 9.3 6.9 1.6 1.1 0.2 16.8 5.9 S: 0
209 81 76 57 57 7.2 7.2 21 21 7.2 1.0 51.4 7.0 7.0 7.3 5.3 2.0 1.0 0.1 14.8 H: 0
ICB Industry : Utilities ICB Sector: Gas; Water & Multiutilities Principal Business: Key membrane bio-reactor supplier inAsia. Also owns a growing portfolio of water assets in China.
Source of all data: Company, DBS Vickers, Bloomberg *Per share estimates based on full CB dilution of 793.1m shares
www.dbsvickers.com Refer to important disclosures at the end of this report ed: OY / sa: JC
Valuations
Sum-of-the-Parts valuation and full dilution assumed for convertible bond. We use sum-ofthe-parts analysis to value UENV so as to capture the different valuation characteristics of the two businesses. At the same time, we have assumed full dilution impact from the S$136.32m Convertible Bond issued to KKR. Based on the conversion price of S$0.45 a share, a total of 302.9m new shares would be issued upon conversion anytime up to 28 Sep, 2016. PE valuation for earnings-driven EPC. Here, we apply 10x PE to FY14F earnings. Our assumed PE multiple is lower than the sector average of 13-14x forward earnings, to factor in UENVs smaller scale of operation.
Peers valuations
Mkt Curry Cap (US$m) Price ($) 12/28/2012 EPS CAGR 11-13 (%) EV/EBITDA (x) 12F 13F Price / BV (x) 12F Net Net Debt/ Debt/ Div Yld (%) Equity Equity PEG 12F 13F 11A (x) 12F (x) 13F
FYE Company
12F
PE (x) 13F
14F
ROE 11A
Hyflux Sound Global Beijing Ent Water China Everbright Intl Tianjin Cap. Environ. Average
7 12 26 8 (8)
29.6x 23.9x 20.5x 14.4x 14.0x 9.2x 8.7x 9.1x 5.3x 5.2x
2.1% 2.1% 2.2% 2.3% 1.7% 2.1% 1.7% 2.0% 2.1% 2.0% 2% 2%
17.9x 14.1x 11.8x 18.2x 15.3x 17.7x 15.0x 13.1x 12.7x 12.1x 9.8x 16.8 9.8x 14.3 8.7x 12.7 7.0x 11.5 6.7x 10.7
United Envirotech
Mar
S$
190
0.49
28
22.1x 8.9x
1.3x
0.6% 1.5%
0.05
0.49
0.3
13%
Page 2
Discounted Cash Flow valuation for the treatment business. Here, we apply a) risk free rate of 1.8% based on DBS Banks forecast yield on a 10-year Singapore government bond b) expected market return of 10% based on Bloombergs 10-year average return of the Singapore market c) the companys adjusted beta of 1.0. Based on these assumptions, we arrive at a weighted average cost of DCF valuation of Treatment business
Risk Free Rate (Rf) Market Return (Rm) Equity risk premium Beta Cost of Equity (Ke) Proportion of financing that is debt After-tax cost of debt (Kd) WACC 1.75% 10.00% 8.25% 1.00 10.0% 40.0% 6.4% 8.6% 1 FY13F 14.9 4.1 (3.7) 0.0 0.0 15.3 14.1
capital of 8.6%. This discount rate applied to the concessions free cash flow forecast yielded an equity value of S$0.50/share for the treatment business. No terminal value is included given that most projects are on a TOT or BOT basis, implying that these would be transferred to the government at the end of the concession period.
DBS forecast of 10 yr T-bond - S'pore Obtained from Bloomberg Market return - risk free rate Obtained from Bloomberg Beta x Equity risk premium Ke = Rf + Debt / (Debt + Equity) Cost of debt * (1-corporate tax rate) WACC = (D/D+E) * Kd + (1 - D/D+E) * Ke 3 FY15F 47.8 9.0 (4.4) 0.0 0.0 52.4 41.0 4 FY16F 47.8 9.0 (9.3) 0.0 0.0 47.6 34.2 5 FY17F 50.0 9.1 (9.6) 0.0 0.0 49.5 32.9 6 FY18F 50.0 9.1 (10.2) 0.0 0.0 48.9 29.9 7 FY19F 50.0 9.1 (15.0) 0.0 0.0 44.1 24.8 8 FY20F 50.0 9.1 (15.0) 0.0 0.0 44.1 22.9 9 FY21F 50.0 9.1 (15.0) 0.0 0.0 44.1 21.1 10 FY22F 50.0 9.1 (15.0) 0.0 0.0 44.1 19.4 11 FY23F 50.0 9.1 (15.0) 0.0 0.0 44.1 17.9 12 FY24F 50.0 9.1 (15.0) 0.0 0.0 44.1 16.5
FYE Mar (S$m) EBIT Add Depreciation & Amortisation Less Tax Provision Less Capex Add changes to working capital Total FCF to the Firm Discounted FCF
Full conversion of CB : +302.9m shares No of shares Terminal Growth (assumed) Total PV of FCF PV of Terminal Value Add Net Cash (Debt) Equity Value (S$m) Value Per Share (S$) 793.1 0% 464.1 0.0 (74.4) 389.7 0.49
Page 3
SOTP target price of S$0.70. Summing up both valuations, we derived a target price of S$0.70 for UENV. Our TP implies 12x FY14F and 10xFY15F, which is still lower than the sector average of 13-14x although UENV features stronger than peers EPS CAGR of 28%. >40% potential return even on conservative assumptions, recommend BUY. Note that our TP is on a fully diluted basis to account for a CB conversion. As the new shares issued will form 38% of the enlarged share capital, a full conversion would trigger a General Offer (based on >30%
threshold). While we have assumed full dilution to be conservative, we believe that conversion would likely be phased out and not all at once. Hence, for comparison purposes, we have also presented a fair value scenario based on the existing share capital. In view of the attractive potential returns of 43% even on a fully diluted TP, and as much as 80% upside if based on existing share cap, we initiate coverage on UENV with a BUY rating.
SOTP fair value of S$0.70 is on fully diluted basis Valuation methodology PER DCF Value per share based on full conversion of CB (S$) 0.20 0.49 Value per share based on existing share cap (S$) 0.33 0.59
FY14 PATMI 16
Fair value Implied upside Implied PER (FY14) Implied PER (FY15)
Source: DBSV estimates
549.8
Page 4
Sales Trend
S$ m S$ m
Profitability Trend
90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0%
60 50 40 30 20 10 2011A 2012A 2013F
Pre tax Profit
300 250 200 150 100 50 0 2011A 2012A 2013F 2014F 2015F
Total Revenue Revenue Growth (%) (YoY)
70
2014F
2015F
Net Profit
Operating EBIT
UENVs principal activities include providing engineering services, turnkey projects, operation and maintenance (O&M) services for water and wastewater facilities. Over the years, UENV has also invested in wastewater treatment plants in China under Build-Operate-Transfer (BOT), Transfer-OperateTransfer (TOT) and/or Build-Operate-Own (BOO) agreements. EPC is the main revenue contributor. For EPC, UENV provides design, fabrication, installation and commissioning of membrane-based water and wastewater treatment systems using advanced membrane technology (e.g. MBR, CMF) processes in micro filtration, ultra filtration, and reverse
osmosis. For the past three years, such services contributed >70% of the companys revenue, with the balance coming from the water and wastewater treatment segment. Investments and O&M provide a steady stream of treatment income. UENVs invested projects are mainly municipal plants from the Chinese government, which generate a steady stream of wastewater treatment tariff receipts for the company. In addition to its own plants, UENV also provides O&M services of water and wastewater treatment facilities to clients on a contractual basis to generate sustainable recurring income.
Page 5
Source: Company
Page 6
UENV has made excellent stride in building up its portfolio of water assets
Phase 1 Investment Investment Design value value capacity RMB m S$ m (m3 / day) 180 100 85 72 200 100 0 69 36 20 17 14 40 20 0 14 161 200,000 80,000 10,000 15,000 80,000 90,000 25,000 50,000 550,000 Phase 2 Design capacity (m3 / day) 200,000 80,000 10,000 40,000 160,000 90,000 50,000 50,000 680,000 Phase 3 Design capacity (m3 / day) 200,000 80,000 10,000 40,000 160,000 90,000 50,000 50,000 680,000
1 2 3 4 5 6 7 8
Date Secured Projects Plant in operation 28-Oct-2004 Liaoyang 14-Sep-2005 Xintai 02-Aug-2006 Nansha 16-Dec-2008 Dafeng 23-Oct-2009 Hegang 31-Aug-2009 Bazhou Mengzhou 29-Sep-2011 Xinmin Total Plant in transition 29-Mar-2012 Changyi 08-Feb-2011 Tangshan 28-Sep-2009 Liaoyang (Hedong) 17-Apr-2012 Shangzhi, Harbin 23-Jul-2012 Changyi 29-Aug-2012 Xintai 20-Sep-2012 Weifang 31-Oct-2012 Qitaihe Total
Province Liaoning Shandong Guangdong Jiangsu Heilongjiang Hebei Henan Liaoning TOT TOT ACQ BOT BOT ACQ ACQ BOT
No. of Source of plants Stake water 1 2 1 2 2 2 1 1 12 100% 100% 100% 100% 100% 40% 40% 100% Municipal Municipal Industrial Industrial Municipal Municipal Industrial Municipal
Plant utilisation 140,000 70,000 7,000 10,000 80,000 63,000 17,500 35,000 422,500 77% 40,000 60,000 140,000 40,000 70,000 14,000 10,000 80,000 454,000 72%
Start date of End date of operation operation May-05 Nov-05 Jan-07 Apr-08 Oct-11 2008 2010 2009 2035 2035 indefinite 2041 2033 2034 2039
Concession period 30 30 30 30 30 24 30
9 10 11 12 13 14 15 16
2 2 2 1 2 1 1 2 13
33 56 49 14 44 20 24 18 258 420
80,000 120,000 200,000 40,000 70,000 20,000 10,000 90,000 630,000 1,180,000
80,000 120,000 200,000 40,000 120,000 40,000 20,000 90,000 710,000 1,390,000 18%
80,000 120,000 200,000 40,000 120,000 40,000 50,000 90,000 740,000 1,420,000 2%
30 30 30 30 30 30 30 30
Total treatment capacity owned Capacity increase over phases O&M 1 06-Jun-12
Liaoyang
Liaoning
O&M
100%
2098
200,000
200,000
200,000
200,000
Jul-14
2033
20
Page 7
Treatment income would grow at 77% CAGR from FY13FY15 to become a steady 60-70% earnings base. Based on processing capacities of 550k m3/day for FY13 and an average utilisation rate of 70-80%, we estimated that Treatment EBIT would hit S$15m in FY13 and S$42m in FY14 as processing capacity increases to 1.18b m3/year next year. This treatment income is expected to be recurring for the 30 year term of the water concession or for as long as the plants .
process wastewater discharged from either the municipalities or industrial parks served. In other words, approximately 6070% of the groups earnings base is stable and recurring. Any upward revision in tariffs, higher utilisation rate, plant expansions and/or acquisitions would result in an upside surprise. Based on S$70m cash on hand, we believe the company can add another 100k m3/day to existing capacity.
wastewater infrastructure from 2011-15. This investment is meant to support the water industry in meeting various targets set in the FYP, through developing more treatment assets and acquiring assets and technology.
Page 8
Improving water quality. The 12th FYP also tightens targets to improve water quality throughout the country. Stricter discharge limits and national drinking water standards have been imposed by the Chinese government of late. The new drinking water standards stipulate 106 regulated items adopted from the World Health Organisation guidelines, up from 35 in the old standards. This has been implemented on 1 July, 2012, affecting both rural and urban areas. Rising demand for plant upgrades to meet higher water discharge standards. Currently, many treatment plants in China lack the capabilities to meet the new water standards. Upgrades and improvements are required to give these plants Water resources per capita
m3 per person 2,500 2,000 1,500 1,000 500 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
a new lease on life, and this drives the growing demand for membrane-based water and wastewater treatment services. A shortage of clean water supply in parts of China also supports this growing demand. UENV should be well placed to benefit from these trends. The increased focus and investment from the Chinese government in the water industry, the stricter water standards driving demand for MBR technology, and the shortage of clean water supply all these factors put UENV in a favourable position to ride the growth path.
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0%
Treated water (LHS) Untreated water sewage (LHS) Sewage rate (RHS)
Page 9
Page 10
UENV has competitive advantage in treating complex wastewater with MBR. With its advanced membrane technology (namely MBR and CMF), UENV is capable of treating wastewater of a greater complexity to meet the stringent standards set, and also to reclaim treated wastewater for reuse more effectively and efficiently. UENVs flagship MBR plant project at Jingxi, Guangzhou, touted as Asias first and largest underground plant of its type generated much hype for the company. The underground design, the membrane technology and its small footprint (only a tenth of a traditional wastewater treatment plant) has attracted a lot of interest from various parts of China and overseas. As such, we are confident that there are many opportunities for UENV in both municipal and industrial sectors.
Some highlights of MBR applications are: Key advantages of MBR Good treated water quality, able to meet more stringent discharge limits, treated water is fit for direct reuse Small space, approximately 20-30% of the traditional treatment plant Generate much less sludge, saves sludge treatment and disposal cost Easy conversion for existing plant upgrading and expansion Application of MBR Biological wastewater treatment Wastewater recycling Wastewater treatment plant upgrade: expand capacity, upgrade facilities within existing plant area to meet more stringent discharge limits
Source:
Page 11
Source:
UENV has been scoring project after project. Less than halfway through FY13, UENV has already announced several successive project clinches in China, proving its commitment to quench the dragons thirst for water. Some of these projects require a higher discharge standard, standing testimony to the companys technical capability and established track record. Of the six projects announced so far, two are EPC projects, while the remaining four are investment in water and wastewater treatment portfolio. For the latest EPC project, it has also signed a 20-year O&M services contract to the same plant.
Table 1: Projects Clinched in FY13 so far
Date 29 Mar 02 Apr 17 Apr 18 Apr 06 Jun 23 Jul Location Shandong, China Fujian, China Heilongjiang, China Shandong, China Liaoning, China Shandong, China Capacity (m3/day) 80,000 150,000 40,000 100,000 200,000 120,000 Value (S$ mn) 33.0 23.2 14.0 43.0 21.0 44.0 Project/Plant Type 1 water supply plant & 1 wastewater treatment plant 2 wastewater treatment plants 1 wastewater treatment plant EPC of drinking water supply plant EPC & O&M to upgrade wastewater treatment plant 2 wastewater treatment plants
Expect to maintain Rmb400m of EPC new win for each of the next two years. We understand UENV is actively pursuing several MBR projects with investment values ranging Rmb300-600m. Based on this strong enquiry pipeline, we estimate that UENV would be able to maintain EPC new order wins of around Rmb400m over the next two years. Orders secured beyond this quantum implies upside surprises to our forecast.
Page 12
8% in income under Dr Lins leadership. He is supported by a strong management team of directors with wide business networks and a wealth of experience.
Designation
Chairman and Chief Executive Officer. Executive Director, Chief Operating Officer Technical Director, Deputy CEO
Mr Tan Huchuan
Oversees the execution of the integrated systems for environmental engineering solutions. Previously a design supervisor at a design institute for the petrochemical industry in Heilongjiang province.
Responsible for the planning and management of the groups financial and accounting operations. Previously an audit manager at Deloitte & Touche Singapore.
Source: Company
Page 13
Key Risks
Collection/credit risks. UENV typically deals with single offtaker for municipal jobs, which is usually the provinces local government. As a result, it is important to assess the financial condition of the respective governments before investing in the project. So far, UENV has not taken on collection of sewage treatment fees as management has been careful in selecting to operate in only the more matured coastal provinces. Most projects are secured in Shandong, Liaoning and Guangdong where UENV is an established incumbent although it also has plants in Heilongjiang and Fujian. Delays in cost pass-through. In general, sewage treatment operators are allowed to pass on higher operating costs arising from inflation or higher electricity tariff to end-users through higher tariffs. However, the approval and actual implementation usually depends on negotiations with the local governments if it is a municipal project. Typically, such negotiations involves months of delays. Utilisation rates significantly below expectations. Generally, operators would negotiate for a minimum off-take level (i.e. take or pay arrangement regardless of volume) in municipal concessions to ensure required returns on their investments are met. However, such minimum off-take arrangements may not always exist for plants in the industrial parks serving private customers. To mitigate such risks, UENV only acquire operating plants in matured industrial parks or economic zones for example Shandongs old textile industry in Shandong which serves the low-end domestic market. Changes in discharge standards. Wastewater treatment plants are usually constructed according to the discharge requirements of the water feed. As of now, less than 10% of treatment plants are graded 1A status, i.e., the highest discharge standard. Any change in discharge standards to stricter limits may result in higher operating and/or investment costs if existing infrastructure is not equipped to process discharge at the new required standard. Fortunately, such risks should be minimal for UENV, which deals mostly with MBR for treating wastewater to meet the highest standards.
Page 14
Key Assumptions
FY Mar 2010A 2011A 2012A 2013F 2014F 2015F
N/A
N/A
280.0
420.0
400.0
400.0
Expect positive environmental protection outlook in China to drive new order wins for UENV
Segmental Breakdown
FY Mar 2010A 2011A 2012A 2013F 2014F 2015F
Revenues (S$ m) EPC Treatment Others 57 12 N/A 62 16 N/A 62 23 N/A 113 37 N/A 80 84 N/A 113 96 N/A
69 14 8 (4)
78 9 9 (4)
85 8 12 (2)
150 28 15 0
164 20 42 0
209 28 48 0
Revenue split is expected to even out between EPC and Treatment as more water plants start contributing next fiscal year
Total
25.5
17.5
20.6
28.7
37.8
36.5
Page 15
Margins Trend
36.0% 31.0% 26.0% 21.0% 16.0% 11.0% 2011A 2012A 2013F 2014F 2015F
Operating Margin % Net Income Margin %
Revenue Cost of Goods Sold Gross Profit Other Opng (Exp)/Inc Operating Profit Other Non Opg (Exp)/Inc Associates & JV Inc Net Interest (Exp)/Inc Exceptional Gain/(Loss) Pre-tax Profit Tax Minority Interest Preference Dividend Net Profit Net Profit before Except. EBITDA Growth Revenue Gth (%) EBITDA Gth (%) Opg Profit Gth (%) Net Profit Gth (%) Margins & Ratio Gross Margins (%) Opg Profit Margin (%) Net Profit Margin (%) ROAE (%) ROA (%) ROCE (%) Div Payout Ratio (%) Net Interest Cover (x)
69 (38) 31 (13) 18 2 0 0 0 19 (4) 0 0 15 15 20 61.3 236.6 261.2 305.4 44.4 25.5 21.5 15.0 10.2 11.2 0.0 58.2
78 (49) 29 (16) 14 5 1 0 0 19 (3) 0 0 16 16 20 12.8 (0.3) (22.7) 7.8 37.7 17.5 20.5 12.6 8.2 6.9 13.7 64.3
85 (47) 38 (21) 18 1 1 (5) 0 14 (4) 0 0 10 10 21 9.4 5.4 28.8 (34.6) 44.8 20.6 12.3 6.6 3.4 4.7 13.7 3.2
150 (90) 60 (17) 43 1 3 (11) 0 36 (9) 0 0 27 27 49 75.6 133.0 144.4 155.8 39.7 28.7 17.9 14.1 6.1 8.4 13.7 3.9
164 (81) 83 (21) 62 1 3 (3) 0 63 (16) 0 0 47 47 68 9.8 37.8 44.9 75.2 50.5 37.8 28.6 16.8 9.2 10.6 13.7 19.2
209 (108) 101 (25) 76 1 3 (4) 0 76 (19) 0 0 57 57 81 26.9 19.9 22.3 20.9 48.3 36.5 27.2 14.8 9.7 11.3 13.7 19.3
Page 16
Asset Breakdown 2 9 77 37 1 38 6 169 6 34 14 2 112 0 169 10 16 161.0 133.9 6.9 0.5 2.0 1.9 CASH CASH 16.4 3.3 13 9 116 47 1 26 10 222 13 23 41 4 141 0 222 14 (7) 148.3 143.6 5.0 0.4 2.3 2.0 0.0 0.0 3.4 1.5 19 16 161 89 0 40 75 401 14 42 162 5 178 0 401 73 (87) 140.3 144.9 4.3 0.3 3.7 2.3 0.5 0.5 4.0 0.0 32 19 261 28 1 60 75 476 14 69 187 5 201 0 476 67 (173) 121.4 144.2 2.9 0.3 2.0 1.1 0.9 0.9 7.5 0.0 35 22 311 30 1 66 75 539 14 71 90 5 359 0 539 70 (74) 139.5 200.1 4.0 0.3 2.0 1.1 0.2 0.2 4.8 0.0 39 25 311 91 1 83 75 626 14 89 110 5 408 0 626 71 (33) 130.5 166.2 3.3 0.4 2.4 1.7 0.1 0.1 4.0 NA UENV has not had problematic collection of sewage treatment fees so far. Management has been careful to operate in established coastal provinces
Inventory 0.6% Bank, Cash and Liquid Assets 20.3% Net Fixed Assets 22.7% Debtors 42.7%
Net Fixed Assets Invts in Associates & JVs Other LT Assets Cash & ST Invts Inventory Debtors Other Current Assets Total Assets ST Debt Other Current Liab LT Debt Other LT Liabilities Shareholders Equity Minority Interests Total Cap. & Liab. Non-Cash Wkg. Capital Net Cash/(Debt) Debtors Turn (avg days) Creditors Turn (avg days) Inventory Turn (avg days) Asset Turnover (x) Current Ratio (x) Quick Ratio (x) Net Debt/Equity (X) Net Debt/Equity ex MI (X) Capex to Debt (%) Z-Score (X)
Assocs'/JVs 13.7%
Page 17
Capital Expenditure
Pre-Tax Profit Dep. & Amort. Tax Paid Assoc. & JV Inc/(loss) Chg in Wkg.Cap. Other Operating CF Net Operating CF Capital Exp.(net) Other Invts.(net) Invts in Assoc. & JV Div from Assoc & JV Other Investing CF Net Investing CF Div Paid Chg in Gross Debt Capital Issues Other Financing CF Net Financing CF Currency Adjustments Chg in Cash Opg CFPS (S cts) Free CFPS (S cts)
19 1 (1) (1) 1 (7) 13 (2) 0 (1) 0 (36) (38) (2) 23 20 (3) 37 (2) 10 2.3 2.3
14 2 (1) (1) (19) 10 5 (7) 0 (20) 0 (75) (102) (1) 5 0 136 139 0 42 5.0 (0.4)
63 2 (9) (3) (10) 0 43 (5) 0 0 0 (50) (55) (6) (97) 117 0 14 0 1 6.6 4.7
Page 18
Margins Trend
35% 30%
Revenue Cost of Goods Sold Gross Profit Other Oper. (Exp)/Inc Operating Profit Other Non Opg (Exp)/Inc Associates & JV Inc Net Interest (Exp)/Inc Exceptional Gain/(Loss) Pre-tax Profit Tax Minority Interest Net Profit Net profit bef Except. EBITDA Growth Revenue Gth (%) EBITDA Gth (%) Opg Profit Gth (%) Net Profit Gth (%) Margins Gross Margins (%) Opg Profit Margins (%) Net Profit Margins (%)
Operating Margin %
Topline growth remains largely driven by EPC sales. Expect Treatment to balance up by FY14
Page 19
DBSV recommendations are based an Absolute Total Return* Rating system, defined as follows: STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame) BUY (>15% total return over the next 12 months for small caps, >10% for large caps) HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps) FULLY VALUED (negative total return i.e. > -10% over the next 12 months) SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies) mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the commodity referred to in this report. DBS Vickers Securities (USA) Inc ("DBSVUSA")"), a U.S.-registered broker-dealer, does not have its own investment banking or research department, nor has it participated in any investment banking transaction as a manager or co-manager in the past twelve months. Any US persons wishing to obtain further information, including any clarification on disclosures in this disclaimer, or to effect a transaction in any security discussed in this document should contact DBSVUSA exclusively. ANALYST CERTIFICATION The research analyst primarily responsible for the content of this research report, in part or in whole, certifies that the views about the companies and their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report. As of 2 Jan 2013, the analyst and his / her spouse and/or relatives who are financially dependent on the analyst, do not hold interests in the securities recommended in this report (interest includes direct or indirect ownership of securities, directorships and trustee positions).
Page 20
COMPANY-SPECIFIC / REGULATORY DISCLOSURES DBS Vickers Securities (Singapore) Pte Ltd and its subsidiaries do not have a proprietary position in the company mentioned as 1. of 28 Dec 2012. 2. DBSVR, DBSVS, DBS Bank Ltd and/or other affiliates of DBS Vickers Securities (USA) Inc ("DBSVUSA"), a U.S.-registered brokerdealer, may beneficially own a total of 1% or more of any class of common equity securities of the company mentioned as of 2 Jan 2013. Compensation for investment banking services: i. ii. DBSVR, DBSVS, DBS Bank Ltd and/or other affiliates of DBSVUSA have received compensation, within the past 12 months, and within the next 3 months receive or intends to seek compensation for investment banking services from Hyflux. DBSVUSA does not have its own investment banking or research department, nor has it participated in any investment banking transaction as a manager or co-manager in the past twelve months. Any US persons wishing to obtain further information, including any clarification on disclosures in this disclaimer, or to effect a transaction in any security discussed in this document should contact DBSVUSA exclusively.
3.
RESTRICTIONS ON DISTRIBUTION General This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation. Australia This report is being distributed in Australia by DBSVR and DBSVS, which are exempted from the requirement to hold an Australian financial services licence under the Corporation Act 2001 [CA] in respect of financial services provided to the recipients. DBSVR and DBSVS are regulated by the Monetary Authority of Singapore [MAS] under the laws of Singapore, which differ from Australian laws. Distribution of this report is intended only for wholesale investors within the meaning of the CA. This report is being distributed in Hong Kong by DBS Vickers (Hong Kong) Limited which is licensed and regulated by the Hong Kong Securities and Futures Commission. This report is being distributed in Singapore by DBSVR, which holds a Financial Advisers licence and is regulated by the MAS. This report may additionally be distributed in Singapore by DBSVS (Company Regn. No. 198600294G), which is an Exempt Financial Adviser as defined under the Financial Advisers Act. Any research report produced by a foreign DBS Vickers entity, analyst or affiliate is distributed in Singapore only to Institutional Investors, Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chap. 289 of Singapore. Any distribution of research reports published by a foreign-related corporation of DBSVR/DBSVS to Accredited Investors is provided pursuant to the approval by MAS of research distribution arrangements under Paragraph 11 of the First Schedule to the FAA. This report is being distributed in the UK by DBS Vickers Securities (UK) Ltd, who is an authorised person in the meaning of the Financial Services and Markets Act and is regulated by The Financial Services Authority. Research distributed in the UK is intended only for institutional clients. This report is being distributed in Dubai/United Arab Emirates by DBS Bank Ltd, Dubai (PO Box 506538, 3 Floor, Building 3, Gate Precinct, DIFC, Dubai, United Arab Emirates) and is intended only for clients who meet the DFSA regulatory criteria to be a Professional Client. It should not be relied upon by or distributed to Retail Clients. DBS Bank Ltd, Dubai is regulated by the Dubai Financial Services Authority. Neither this report nor any copy hereof may be taken or distributed into the United States or to any U.S. person except in compliance with any applicable U.S. laws and regulations. In any other jurisdictions, except if otherwise restricted by laws or regulations, this report is intended only for qualified, professional, institutional or sophisticated investors as defined in the laws and regulations of such jurisdictions. DBS Vickers Research (Singapore) Pte Ltd 12 Marina Boulevard, Level 40, Marina Bay Financial Central Tower 3, Singapore 018982 Tel. 65-6327 2288 Company Regn. No. 198600295W
rd
Hong Kong
Singapore
United Kingdom
Other jurisdictions
Page 21